Sadek Debwan — TMS Medicare billing
MD · Neuropsychiatry · Fairfield, CA
TMS provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Services (2024)
1,049
Patient bounds
24–41
Services per patient (bounds)
25.6–43.7
Estimated Medicare paid
$173,857
National provider median $51,810
National peer context
#20 of 391 published TMS providers by screening score/payment in 2024 · 0.49% of national published TMS payment. This rank is not a clinical assessment.
Peer evidence
Screening score 22 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
No NPI match in the saved OIG LEIE copy—not a clearance.
Year-over-year Medicare payments
CMS billing detail — 2024
Fetched 2026-11-07T23:23:37.341Z · Complete three-code cohort
| Code / treatment | Services | Patient bounds | Services / patient | Medicare paid |
|---|---|---|---|---|
| 90867 Initial treatment + motor-threshold determination | 18 | 17–17 | 1.1–1.1 | $4,546 |
| 90868 Subsequent treatment | 1,031 | 24–24 | 43.0–43.0 | $169,311 |
Peer evidence
Screening score 22 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
CMS billing detail — 2023
Fetched 2026-11-07T23:23:27.130Z · Complete three-code cohort
| Code / treatment | Services | Patient bounds | Services / patient | Medicare paid |
|---|---|---|---|---|
| 90868 Subsequent treatment | 272 | 11–11 | 24.7–24.7 | $37,963 |
Peer evidence
Screening score 1 · Low; highest same-code/setting shared peer score, not a probability of fraud.
No threshold flags in the available same-code/setting comparisons. This is not a clearance.
Medicare Part B fee-for-service only; Medicare Advantage, Medicaid and commercial claims are excluded. CMS suppresses provider-code rows with fewer than 11 beneficiaries. Patient counts overlap across codes and settings; bounds are not unique national patients. Annual aggregates cannot establish treatment courses, failure, medical necessity, duplicate visits or fraud. Coverage varies by Medicare contractor; no Spravato dosing thresholds are applied.
